LncRNA MINCR靶向miR-223抑制LPS诱导的人肺泡上皮细胞系A549损伤和炎性反应

doi:10.16352/j.issn.1001-6325.2023.01.0102

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (1): 102-109.doi: 10.16352/j.issn.1001-6325.2023.01.0102

LncRNA MINCR靶向miR-223抑制LPS诱导的人肺泡上皮细胞系A549损伤和炎性反应

杨广林, 任丽娟, 陈文静, 熊维军^*

四川护理职业学院附属医院/四川省第三人民医院呼吸内科,四川成都 610100

收稿日期:2021-12-31 修回日期:2022-05-09 发布日期:2022-12-27
通讯作者: ^*763840401@qq.com
基金资助:
四川省卫生和计划生育委员会科研课题(18PJ108)

LncRNA MINCR inhibits LPS-induced damage and inflammation of alveolar epithelial cell line A549 by targeting at miR-223

YANG Guanglin, REN Lijuan, CHEN Wenjing, XIONG Weijun^*

Department of Respiratory Medicine, Affiliated Hospital of Sichuan Nursing Vocational College/ the Third People's Hospital of Sichuan Province, Chengdu 610100, China

Received:2021-12-31 Revised:2022-05-09 Published:2022-12-27
Contact: ^*763840401@qq.com

摘要/Abstract

摘要： 目的探讨长链非编码RNA(lncRNA)MINCR靶向调节微小RNA(miR)-223对脂多糖(LPS)诱导的肺泡上皮细胞系损伤和炎性反应的影响。方法将人肺泡上皮细胞系A549随机分为对照组、LPS组、LPS+转染组(Si NC组、Si MINCR组、miR-223 NC组、miR-223 mimic组、Si NC+miR-223 NC组、Si NC+miR-223 antagomir组、Si MINCR+miR-223 NC组、Si MINCR+miR-223 antagomir组)。RT-qPCR检测MINCR、miR-223表达水平;流式细胞仪检测细胞凋亡率;ELISA测定血清中肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平;生物信息学预测和双荧光素酶报告基因验证MINCR与miR-223的靶向关系;Western blot检测细胞中活化的半胱天冬氨酸蛋白酶-3(cleaved caspase-3)、B细胞淋巴瘤-2(Bcl-2)蛋白表达水平。结果 MINCR和miR-223存在靶向关系。LPS组与对照组比较,细胞凋亡率、TNF-α、IL-6水平、MINCR、cleaved caspase-3蛋白表达均显著增加(P<0.05),miR-223、Bcl-2蛋白表达显著降低(P<0.05)。与Si NC组相比,Si MINCR组细胞凋亡率、TNF-α和IL-6水平、MINCR和cleaved caspase-3蛋白表达均显著降低(P<0.05),Bcl-2蛋白表达显著升高(P<0.05);与miR-223 NC相比,miR-223 mimic组细胞凋亡率、TNF-α和IL-6水平、cleaved caspase-3蛋白表达均显著降低(P<0.05),miR-223、Bcl-2蛋白表达显著升高(P<0.05)。miR-223 antagomir可逆转Si MINCR发挥的作用(P<0.05)。结论沉默lncRNA MINCR的表达可能通过靶向激活miR-223表达,抑制A549细胞凋亡以及炎性反应,减少LPS诱导的A549细胞损伤。

关键词: 肺泡上皮细胞, lncRNA MINCR, miR-223, 炎性反应, 细胞损伤

Abstract: Objective To investigate the potential effects of long non-coding RNA (lncRNA) MINCR on lipopolysaccharide (LPS)-induced human alveolar epithelial cell line A549 damage and inflammation through targeted regulation of miR-223. Methods A549 cells were randomly divided into control group, LPS group, LPS+transfection group(Si NC group, Si MINCR group, miR-223 NC group, miR-223 mimic group, Si NC+miR-223 NC group, Si NC+miR-223 antagomir group, Si MINCR+miR-223 NC group, and Si MINCR+miR-223 antagomir group). RT-qPCR was performed to determine the expression levels of MINCR and miR-223; Flow cytometry was performed to determine the rate of apoptosis; ELISA was performed to determine the levels of serum tumor necrosis factor-α(TNF-α) and interleukin-6 (IL-6); Bioinformatics prediction and dual luciferase reporter gene assay were performed to verify the targeting relationship of MINCR and miR-223; Western blot was performed to test the expression levels of activated caspase-3 (cleaved caspase-3) and B-cell lymphoma-2(Bcl-2) proteins in the cells. Results There was a targeting relationship between MINCR and miR-223. Compared with the control group, the apoptosis rate, the level of TNF-α and IL-6, and the expression of MINCR, cleaved caspase-3 proteins in the LPS group were significantly increased (P<0.05).The expression of miR-223 and Bcl-2 proteins significantly decreased(P<0.05). Compared with the Si NC group, the apoptosis rate, the levels of TNF-α and IL-6, and the expression of MINCR and cleaved caspase-3 proteins in the Si MINCR group were obviously reduced (P<0.05); And the expression of Bcl-2 protein was obviously increased (P<0.05). Compared with miR-223 NC, the apoptosis rate, the levels of TNF-α and IL-6, and the expression of cleaved caspase-3 protein in the miR-223 mimic group were obviously reduced (P<0.05); And the expression of miR-223 and Bcl-2 proteins was obviously increased (P<0.05). miR-223 antagomir was able to reverse the effect of Si MINCR (P<0.05). Conclusions Silencing the expression of lncRNA MINCR may target the activation of miR-223 expression, inhibit cell apoptosis and inflammation, and reduce LPS-induced damage of alveolar epithelial cells.

Key words: alveolar epithelial cells, lncRNA MINCR, miR-223, inflammation, cell damage

中图分类号:

R563

杨广林, 任丽娟, 陈文静, 熊维军. LncRNA MINCR靶向miR-223抑制LPS诱导的人肺泡上皮细胞系A549损伤和炎性反应[J]. 基础医学与临床, 2023, 43(1): 102-109.

YANG Guanglin, REN Lijuan, CHEN Wenjing, XIONG Weijun. LncRNA MINCR inhibits LPS-induced damage and inflammation of alveolar epithelial cell line A549 by targeting at miR-223[J]. Basic & Clinical Medicine, 2023, 43(1): 102-109.

参考文献

[1] Curley G, Hayes M, Laffey JG. Can ‘permissive’ hypercapnia modulate the severity of sepsis-induced ALI/ARDS?[J]. Crit Care, 2011, 15:212. doi: 10.1186/cc9994.
[2] 戴春威, 贾珊, 陈敏, 等. miR-486调控PTEN影响LPS诱导的肺泡上皮细胞A549凋亡的实验研究[J]. 中国病理生理杂志, 2019, 35:1838-1843.
[3] 李维维, 葛斌, 邓涛,等. miR-17-5p靶向乙醛脱氢酶2减少肺炎链球菌诱导的人肺腺癌肺泡基底上皮细胞系A549损伤[J]. 基础医学与临床, 2020, 40:1362-1368.
[4] Lyu Q, Jin L, Yang X, et al. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma[J]. Pathol Res Pract, 2019, 215:924-930.
[5] Iacona JR, Monteleone NJ, Lutz CS. miR-146a sup-presses 5-lipoxygenase activating protein (FLAP) expression and Leukotriene B4 production in lung cancer cells[J]. Oncotarget, 2018, 9:26751-26769.
[6] Sedgeman LR, Michell DL, Vickers KC. Integrative roles of microRNAs in lipid metabolism and dyslipidemia[J]. Curr Opin Lipidol, 2019, 30:165-171.
[7] 亓水芹, 冯向功. miR-221靶向AdipoR1基因对LPS诱导的肺泡上皮细胞A549炎症分泌及凋亡影响[J]. 中国免疫学杂志, 2020, 36:538-543.
[8] Cao C, Yin C, Shou S, et al. Ulinastatin protects against LPS-induced acute lung injury by attenuating TLR4/NF-κB pathway activation and reducing inflammatory mediators[J]. Shock, 2018, 50:595-605.
[9] Saguil A, Fargo MV. Acute respiratory distress syndrome: diagnosis and management[J]. Am Fam Physician, 2020, 101:730-738.
[10] Li H, Shi H, Ma N, et al. BML-111 alleviates acute lung injury through regulating the expression of lncRNA MALAT1[J]. Arch Biochem Biophys, 2018, 649:15-21.
[11] Gao W, Zhang Y. Depression of lncRNA MINCR antagonizes LPS-evoked acute injury and inflammatory response via miR-146b-5p and the TRAF6-NFkB signaling[J]. Mol Med, 2021, 27:124. doi: 10.1186/s10020-021-00367-3.
[12] 洪爱玲, 朱海燕, 何贵清, 等. miRNA-223靶向FoxO3抑制肺结核大鼠巨噬细胞凋亡研究[J]. 浙江医学, 2019, 41:1610-1613.
[13] Hong J, Mo S, Gong F, et al. LncRNA-SNHG14 plays a role in acute lung injury induced by lipopolysaccharide through regulating autophagy via miR-223-3p/Foxo3a[J]. Mediators Inflamm, 2021:7890288. doi: 10.1155/2021/7890288.
[14] Zhong Q, Chen Y, Chen Z. LncRNA MINCR regulates irradiation resistance in nasopharyngeal carcinoma cells via the microRNA-223/ZEB1 axis[J]. Cell Cycle,2020, 19:53-66.

[1]	付士祥, 席月, 丁龙坤, 闫曼, 赵俊, 焦玉东, 吴亮. 鲍曼不动杆菌外膜囊泡诱发人单-核巨噬细胞THP-1的炎性反应[J]. 基础医学与临床, 2023, 43(1): 110-115.
[2]	曾颖, 付桂莉. 黄芩提取物抑制IL-22诱导的人角质形成细胞系HaCaT过度增殖[J]. 基础医学与临床, 2023, 43(1): 123-129.
[3]	顾炜, 祝剑平, 吴品雯. 丙泊酚减轻低氧诱导的大鼠肾上腺嗜铬细胞瘤细胞系PC12炎性反应和细胞凋亡[J]. 基础医学与临床, 2023, 43(1): 137-143.
[4]	黄华, 周龙, 姚迪, 许诣. LncRNA PVT1 通过调节miR-214/STAT6 轴减轻哮喘模型小鼠气道炎性反应[J]. 基础医学与临床, 2022, 42(9): 1374-1380.
[5]	谷文浩, 郭飞霞, 徐宇鹏, 陆馨雨, 胡青青. 淫羊藿苷改善重症急性胰腺炎模型大鼠肺损伤[J]. 基础医学与临床, 2022, 42(9): 1400-1405.
[6]	刘珍竹, 李靖, 何丹, 曲鹏. PI3K信号通路调控动脉粥样硬化发生发展的研究进展[J]. 基础医学与临床, 2022, 42(9): 1428-1432.
[7]	杨雄, 靳潇潇, 何文强. 肾上皮细胞损伤与肾结石Randall斑块形成[J]. 基础医学与临床, 2022, 42(9): 1454-1458.
[8]	童晓维, 肖韩. miR-223抑制肺结核大鼠肺部病变[J]. 基础医学与临床, 2022, 42(8): 1225-1229.
[9]	王珊, 杨华昱, 孙颖, 马清. 老年血液透析患者血清miR-21与T细胞相关[J]. 基础医学与临床, 2022, 42(8): 1188-1193.
[10]	王远卓, 郑清月, 张翰林, 仇文颖, 王涛, 马超. 小胶质细胞在阿尔茨海默病神经炎性反应中作用的研究进展[J]. 基础医学与临床, 2022, 42(8): 1310-1313.
[11]	李潇潇, 舒祥兵, 张莉. 胆固醇代谢与非酒精性脂肪性肝炎的研究进展[J]. 基础医学与临床, 2022, 42(7): 1134-1138.
[12]	姜秀芳, 耿亚楠, 阳盛洪, 魏平, 赵名, 朱玲玲. 绞股蓝皂苷减轻脂多糖诱导大鼠肾上腺嗜铬细胞瘤细胞系PC12损伤[J]. 基础医学与临床, 2022, 42(6): 908-912.
[13]	康锦钰, 罗佳, 高泽天, 郑文涛, 刘爱明, 宋毓飞. 胆汁淤积性肝损伤炎性反应机制的研究进展[J]. 基础医学与临床, 2022, 42(5): 809-813.
[14]	李蓉, 朱含月. 酮咯酸氨丁三醇抑制膝骨关节炎模型大鼠炎性反应[J]. 基础医学与临床, 2022, 42(3): 417-422.
[15]	张琦悦, 张伟丽. 血管老化在动脉粥样硬化中的研究进展[J]. 基础医学与临床, 2022, 42(3): 372-377.

LncRNA MINCR靶向miR-223抑制LPS诱导的人肺泡上皮细胞系A549损伤和炎性反应

LncRNA MINCR inhibits LPS-induced damage and inflammation of alveolar epithelial cell line A549 by targeting at miR-223

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价